ESCMID Conference on Reviving Old Antibiotics
22 - 24 October 2014, Vienna, Austria
Poster Presentations
Posters will be presented on 22 - 23 October 2014.
P01 | Efficacy of Old Antibiotics against Commonly Isolated Microorganisms in a Tertiary Care Hospital | Majumder, S. (India) |
P02 | Comparative in vitro activity of temocillin and other beta-lactams against Pseudomonas aeruginosa isolated from cystic fibrosis patients | Chalhoub, H. (Belgium) |
P03 | In vitro activity of Fosfomycin and Tigecycline against Carbapenemase Producing Enterobacteriacae in a tertiary care hospital in Singapore | Choudhury, S. (Singapore) |
P04 | In vitro Activity of Nitroxoline | Naber, K.G. (Germany) |
P05 | Prevalence of multidrug resistant Klebsiella pneumoniae strains producing carbapenemases (MDR-KPC) and increase of resistance to colistin | Bartolini, A. & Santacatterin, E. (Italy) |
P06 | Old Drugs for New Bugs, the Chaotic Lebanese Scenario: A Developing Country's Perspective | Bizri, A. (Lebanon) |
P07 | Resistant strains of Acinetobacter baumannii and Pseudomonas aeruginosa from intensive care unit | Yergaliyeva, A. (Kazakhstan) |
P08 | Prevalence and Antimicrobial Susceptibility Pattern of Extended Spectrum Beta Lactamase (ESBL) and non-ESBL Producing Enteric gram-negative Bacteria and Activity of Nitrofurantoin in the Era of ESBL | Fatemi, A. (Iran) |
P09 | INFLUENCE OF ANTIBIOTIC GENTAMICIN ON MITOGEN-INDUCED TRYPTOPHAN BREAKDOWN IN VITRO | Gostner, J.M. (Austria) |
P10 | IN VITRO ACTIVITY OF RIFAXIMIN COMBINED WITH COLISTIN OR POLYMYXIN B VERSUS MULTI-DRUG RESISTANT GRAM-NEGATIVE BACTERIA. A POTENTIAL COMBINATION REGIMEN FOR SELECTIVE DECOMNTAMINATION OF THE DIGESTIVE TRACT? | Betts, J.W. (United Kingdom) |
P11 | THE INVESTIGATION OF COLISTIN RESISTANCE MECHANISMS IN CLINICAL ISOLATES OF KLEBSIELLA PNEUMONIAE | Kocsis, B. (Hungary) |
P12 | A deletion in lumazine synthase contributes to nitrofurantoin resistance in Escherichia coli | Xavier, B.B. (Belgium) |
P13 | Resistance CAMRSA isolates from healthy population to non beta-lactam antibiotics in Pomoravlje district | Petrović Jeremić, L.J. (Serbia) |
P15 | High macrolide resistant Moraxella catarrhalis and development of an allele-specific PCR assay for detection of 23S rRNA gene A2330T mutation: A 3 year study at a Chinese tertiary hospital | Liu, Y.L. (China) |
P17 | Heteroresistance to colistin in Klebsiella pneumoniae | Xavier, B.B. (Belgium) |
P18 | A NOVEL TRIPLE COMBINATION OF FOSFOMYCIN, CHLORAMPHENICOL AnD COLISTIN FOR THE TREATMENT OF PSEUDOMONAS AERUGINOSA INFECTION | Betts, J.W. (United Kingdom) |
P19 | INTERACTIONS BETWEEN DOXYCYCLINE AND NON-ANTIBIOTIC DRUGS USED IN CANINE MEDICINE | Maaland, M.G. (Denmark) |
P20 | Bactericidal activity of Ciprofloxacin Dry Powder for Inhalation (DPI) in a hollow fiber (HF) model | Glenschek-Sieberth, M. (Germany) |
P21 | GALLERIA MELLONELLA: AN IN VIVO MODEL FOR ASSESSING THE EFFICACY OF COLISTIN COMBINATIONS WITH BROAD SPECTRUM ANTIBIOTICS AGAINST BIOFILM FORMING ACINETOBACTER BAUMANNII INFECTIONS | Gillett, A.R. (United Kingdom) |
P22 | NOVEL ANTIVIRULENCE AGENTS SENSITIZE MRSA TO BETA-LACTAM ANTIBIOTICS | Shoham, M. (United States) |
P23 | Phosphonopeptides Revisited, in the Era of Multidrug-Resistant Enterobacteriaceae | Marrs, E.C.L. (United Kingdom) |
P24 | Method for detecting levels of antibiotics in blood paves the way to individualized treatments | Wafula Ndieyira, J. (United Kingdom) |
P25 | PHARMACOKINETICS OF COLISTIN AFTER THE ADMINISTRATION OF TWO DIFFERENT LOADING DOSES OF COLISTIN METHANESULFONATE (CMS) IN CRITICALLY ILL PATIENTS | Pachón- Ibañez, M.E. (Spain) |
P26 | Clinical Pharmacokinetics of Temocillin in Patients With End Stage Renal Disease Undergoing Haemodialysis | Miranda Bastos, A.C. (Belgium) |
P27 | DIFFERENCE IN CLEARANCE OF VANCOMYCIN BY RAC | Sungmin Kiem (Rep. of Korea) |
P28 | Revisiting paediatric penicillin pharmacokinetics: the feasIbility of opportunistic sampling strategies | Barker, C.I. (United Kingdom) |
P29 | RISK ASSESSMENT FOR AMIKACIN INHALE IN ICU PATIENTS USING WHOLE-BODY PHYSIOLOGICALLY-BASED PK-MODELS | Stass, H. (Germany) |
P30 | LUNG DEPOSITION OF CIPROFLOXACIN DPI IN HEALTHY VOLUNTEERS AND PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) OR NON-CYSTIC FIBROSIS BRONCHIECTASIS (NCFB) | Stass, H. (Germany) |
P31 | Efficacy of ciprofloxacin against resistant P. aeruginosa isolated from non-cystic fibrosis bronchiectasis (NCFB) patients considering lung pharmacokinetics (PK) after Ciprofloxacin DPI treatment | Glenschek-Sieberth, M. (Germany) |
P32 | Inhalatory antibiotic therapy in cystic fibrosis and emergence of colistin resistant gram-negative non-fermenting bacteria: a new problem in pulmonary infection treatment? | Morelli, P. (Italy) |
P33 | STUDY OF THE USE OF COLISTIN IN A LARGE ORTHOPEDIC/TRAUMA HOSPITAL OF GREECE | Stefani, D. (Greece) |
P34 | Multiple-dose regimen of intravenous and oral fosfomycin tromethamine as a potential therapy for the treatment of systemic infections due to multidrug-resistant bacteria | Ortiz Zacarías N.V. (Netherlands) |
P35 | NITROXOLINE FOR TREATMENT OF UNCOMPLICATED UTI IPD-METAANALYSIS OF FOUR CONTROLLED CLINICAL STUDIES | Naber, K.G. (Germany) |